Comparison of Ranolazine and Trimetazidine on Glycemic Status in Diabetic Patients with Coronary Artery Disease – A Randomized Controlled Trial

Comparison of Ranolazine and Trimetazidine on Glycemic Status in Diabetic Patients with Coronary Artery Disease – A Randomized Controlled Trial

Introduction: Cardiovascular diseases have become the leading cause of death around the globe and diabetes mellitus (DM) is considered to be a coronary artery disease (CAD) risk equivalent. Ranolazine, an anti anginal drug has been found to reduce Glycated haemoglobin (HbA1c) in diabetes patient...

Full description

Bibliographic Details
Main Authors: Sandhiya Selvarajan, Steven Aibor Dkhar, Ajith Ananthakrishna Pillai, Melvin George, Balachander Jayaraman, Adithan Chandrasekaran
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2015-01-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
glycemic status
hba1c
qtc
ranolazine
trimetazidine
Online Access:https://jcdr.net/articles/PDF/5448/10594_CE(RA1)_F(T)_PF1(NJAK)_PF2(PAK)_PFA(AK)_PF2(PAG).pdf

Internet

https://jcdr.net/articles/PDF/5448/10594_CE(RA1)_F(T)_PF1(NJAK)_PF2(PAK)_PFA(AK)_PF2(PAG).pdf

Similar Items